Drug Profile
BL 1020
Alternative Names: AN-168; BL-1020; CYP-1020; Perphenazine GABA ester; Perphenazine-4-aminobutyrateLatest Information Update: 18 Mar 2014
Price :
$50
*
At a glance
- Originator Bar-Ilan University; Tel Aviv University
- Developer BioLineRx
- Class Antipsychotics; Esters; Phenothiazines; Piperidines; Small molecules
- Mechanism of Action Dopamine receptor antagonists; GABA receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Discontinued Schizoaffective disorder; Schizophrenia
Most Recent Events
- 18 Mar 2014 Discontinued - Phase-II for Schizoaffective disorder in Israel (PO)
- 18 Mar 2014 Discontinued - Phase-II for Schizoaffective disorder in Romania (PO)
- 18 Mar 2014 Discontinued - Phase-II for Schizophrenia in Israel (PO)